DW Healthcare Partners acquired control of Bio Agri Mix, LP from Birch Hill Equity Partners Inc. CEO Robert Bell and founder Chairman Paul Lake remain as shareholders and continue to lead the companyContinue Reading
Lumira Capital Investment Management, dba Lumira Ventures, held final close for Lumira Ventures IV with total capital commitment of US $220M, and US $35M strategic venture fund with an unnamed international pharmaceutical companyContinue Reading
Coloursmith Labs secured $2M seed funding led by Sandpiper Ventures with participation of pre-seed investors Brigus Capital Inc., Island Capital Partners LP, and Killick Venture Fund LP.
Continue Reading
Turnstone Biologics closed US $80M Series D from PFM Health Sciences, Point72, Eventide Asset Management, Surveyor Capital, Ridgeback Capital Investments, Takeda Ventures Inc., CaaS Capital, JM Family Enterprises, Northleaf, 404 Bio, Versant Ventures, OrbiMed, F-Prime Capital, Sectoral Asset Management, Sixty Degree Capital, Brace Pharma Capital and Teralys Capital.Continue Reading
Comet Bio secured $22M Series C funding from Open Prairie, Louis Dreyfus Company (LDC), BDC Cleantech Practice, Sofinnova Partners and othersContinue Reading
Cornell Capital and Caisse de dépôt et placement du Québec backed Knowlton Development Corporation, Inc. (kdc/one) filed for initial public offering (IPO) on TSX and NYSEContinue Reading
Incisive Genetics Inc. closed $2.5M tranched seed financing with a private investor syndicate led by investors Noel Hall and Sandra MacPherson of the MacHall group and Haig Farris, OC.
Continue Reading
Frazier Healthcare Partners backed Parata System acquired Synergy Medical from founder and President Jean Boutin who will continue Synergy MedicalContinue Reading
Giiant Pharma added additional $1.25M seed funding from AQC Capital ($750K) and CQDM ($500K) to initial US $11M seed round led by Amplitude Ventures and Genesys CapitalContinue Reading
Adela secured US $60M Series A from F-Prime Capital, OrbiMed, Deerfield Management, Decheng Capital, and RA Capital Management. Adela’s major operations will based at University Health Network (UHN) campus and headquartered in New Haven, ConnecticutContinue Reading
Orion Biotechnology Canada Ltd. closed US $11.5M Series A private financing with Keiretsu Forum members and a large group of Canadian and foreign private investorsContinue Reading
Trait Biosciences secured $31M Series A (new cash and the conversion of bridge financing debt) from Gotham Green Partners (GGP), Btomorrow Ventures and other investors.Continue Reading
Brains Bioceutical Corp. closed US $31.9M new funding round led by DSM Venturing with participation of existing Canadian, American and international private investors.Continue Reading
Danaher acquired Precision NanoSystems from founders James Taylor and Euan Ramsay, and backers 5AM Ventures, Telegraph Hill Partners, Rising Tide Fund, Quimby Investments (VCC) Ltd., and othersContinue Reading
Frazier Healthcare Partners closed its 10th dedicated middle market healthcare private equity fund, Frazier Healthcare Growth Buyout Fund X, L.P. at hard cap of US $1.4B.
Continue Reading
Giiant Pharma officially announced closing of US $11M seed funding from Amplitude Ventures, Genesys Capital, Fonds de solidarité FTQ, AmorChem II Fund, Theodorus Investment Funds, Anges Québec, and private investors.
Continue Reading
OMERS Private Equity to acquire Gastro Health from Audax Private Equity for undisclosed amount. The transaction is expected to close in Q2 2021.Continue Reading
